Dr. Drew S. Dill, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 765
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
TN license 48960 · AR license E-8632 · MS license 24828
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Methodist Hospitals of Memphis Memphis, TN
- Baptist Memorial Hospital Memphis, TN
- Baptist Memorial Hospital Desoto Southaven, MS
- Baptist Memorial Hospital Tipton Covington, TN
- Saint Francis Bartlett Medical Center Bartlett, TN
Medical groups
- Baptist Memorial Medical Group, Inc. (576 clinicians)
- Baptist Memorial Hospital-Tipton (29 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 765
- Services billed
- 3,063
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 676 | 392 |
| Established patient office or other outpatient visit, 30-39 minutes | 261 | 244 |
| New patient office or other outpatient visit, 60-74 minutes | 149 | 149 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 141 | 67 |
| Established patient office or other outpatient visit, 20-29 minutes | 83 | 81 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 59 | 51 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 19 | 18 |
| Insertion of needle into vein for collection of blood sample | 16 | 15 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | 14 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Letrozole Other prescribers in Memphis, TN | 380 |
| Eliquis (apixaban) Other prescribers in Memphis, TN | 202 |
| Ondansetron Odt (ondansetron) Other prescribers in Memphis, TN | 114 |
| Tamoxifen Citrate Other prescribers in Memphis, TN | 88 |
| Dexamethasone Other prescribers in Memphis, TN | 86 |
| Xarelto (rivaroxaban) Other prescribers in Memphis, TN | 75 |
| Pantoprazole Sodium Other prescribers in Memphis, TN | 63 |
| Verzenio (abemaciclib) | 56 |
| Acyclovir Other prescribers in Memphis, TN | 51 |
| Hydroxyurea Other prescribers in Memphis, TN | 50 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 67 payments worth $1,483 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $203 |
|---|---|
| E.r. Squibb & Sons, L.l.c. | $174 |
| Daiichi Sankyo Inc. | $130 |
| Celgene Corporation | $129 |
| GlaxoSmithKline, LLC. | $120 |
| Pfizer Inc. | $115 |
| Tempus Ai, Inc | $97.39 |
| AbbVie Inc. | $68.73 |
| Food and Beverage | $1,408 |
|---|---|
| Education | $75.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Aug 18, 2025 | Education in-kind Company’s descriptionEducational Item | $75.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.